These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 6750451)
1. Immunologic approaches to the diagnosis and treatment of malignant disease. Coral FS NITA; 1982; 5(4):256-61. PubMed ID: 6750451 [No Abstract] [Full Text] [Related]
2. [Cancer immunotherapy targeting WT1 product which overexpressess in various kinds of malignant neoplasms]. Oka Y; Tsuboi A; Sugiyama H Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1663-70. PubMed ID: 12931627 [No Abstract] [Full Text] [Related]
3. [1st immunologic attempts in the treatment of human malignant tumors]. Mannelli MA Minerva Med; 1977 Apr; 68(19):1301-4. PubMed ID: 854230 [No Abstract] [Full Text] [Related]
4. Immunological approaches to the treatment of malignant disease. Guillou PJ J R Coll Surg Edinb; 1988 Feb; 33(1):2-8. PubMed ID: 2458468 [No Abstract] [Full Text] [Related]
5. The immune system and cancer. Gallucci B Oncol Nurs Forum; 1987; 14(6 Suppl):3-12. PubMed ID: 3320984 [No Abstract] [Full Text] [Related]
6. Immunologic aspects of malignancy: Factors of concern in the prospective candidate for immunotherapy. Ablin RJ Allergol Immunopathol (Madr); 1975; 3(2):105-8. PubMed ID: 1155313 [No Abstract] [Full Text] [Related]
7. [Progress in immunology. Therapeutic aspects in clinical medicine]. Wirth W Med Welt; 1982 Dec; 33(51-52):1859-60. PubMed ID: 7162406 [No Abstract] [Full Text] [Related]
8. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
11. [Thymus hormones in the immunotherapy of malignant neoplasms (a review of the literature)]. Nikol'skiĭ IS Vrach Delo; 1988 Aug; (8):77-82. PubMed ID: 3061171 [No Abstract] [Full Text] [Related]
12. [Immunology: new approaches to immuno-modulation and immunotherapy]. Kabelitz D Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979 [No Abstract] [Full Text] [Related]
13. [Antibody and immunotherapy in oncology. Which patients benefit?]. Schlimok G MMW Fortschr Med; 2001 Jun; 143(25):24-8. PubMed ID: 11468992 [TBL] [Abstract][Full Text] [Related]
14. [Immunotherapy for cancer--modern immunologic strategies in oncology]. Halama N; Zoernig I; Jäger D Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564 [TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy of malignant growth]. Tobiasch V Lebensversicher Med; 1986 Sep; 38(5):133-9. PubMed ID: 2877376 [No Abstract] [Full Text] [Related]
16. [Cancer and immune defense]. Sollid LM; Thrane PS; Brandtzaeg P Tidsskr Nor Laegeforen; 1988 May; 108(15):1205-9. PubMed ID: 3291190 [No Abstract] [Full Text] [Related]
17. Cancer immunotherapy. Schuster M; Nechansky A; Kircheis R Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244 [TBL] [Abstract][Full Text] [Related]